Testing MR-guided radiation checks for glioblastoma
Part of Cancer clinical trials.
This study tests how best to measure and track glioblastoma treatment while using MRI (a body scanner) to guide radiation. It may help improve how doctors assess the radiation response during therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of glioblastoma (GBM) from a tissue sample (biopsy/surgery)
- Your doctor has decided you need radiation treatment given in multiple sessions for GBM
- You are age 18 or older
- You can do the MRI and radiation visits on schedule, and follow study instructions
- You must be able to do MRI scans if you feel claustrophobic (closed-space anxiety)
- Your overall ability to function is good enough (Karnofsky score 60 or higher)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses special MRI imaging with deuterium to see how radiotherapy affects newly diagnosed glioblastoma (GBM) with an IDH-wildtype tumor. It may help doctors better understand treatment response and timing, potentially improving how radiotherapy is planned.
This study uses special MRI scans to measure oxygen levels in and around glioblastoma before and during radiation treatment. It may help researchers understand how oxygen affects treatment response and timing.
This study is testing whether special MRI scans and blood tests can help tell the difference between true tumor growth (progression) and a treatment-related reaction called 'pseudoprogression' in people with glioblastoma. The goal is to make treatment decisions more accurate.
This trial tests a new approach to radiation therapy for newly diagnosed, aggressive brain tumors. It uses an MRI-guided machine (MR-linac) to deliver radiation more precisely, while studying how to make treatment safer and more effective.
This trial tests whether using advanced MRI scans before radiation therapy can help doctors target the tumor more precisely and possibly improve outcomes for people with glioblastoma. It aims to make radiation treatment more personalized.
This study uses repeated MRI scans with a contrast dye to help doctors tailor (adapt) your radiation treatment over time for a high-grade glioma. It may help improve how accurately radiation targets the tumor as it changes.
Hear when a new Glioblastoma Multiforme trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.